Board Advisor

Heidi Hunter is a global biotechnology leader with extensive experience across innovation, biosimilars and speciality pharmaceuticals, spanning the clinical and commercial value chain. She most recently served as President of Cardinal Health Specialty Solutions, overseeing six businesses with more than 6 billion dollars in revenue. Previously, she led an immunology business in Brussels and built an integrated biologics clinical development programme.